[1] |
Ning Ma, Chao Ji.
Acetylcholine ameliorates inflammatory microenvironment via regulating the balance of IL-1β/IL-1RA
[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 260-267.
|
[2] |
Yingzheng Wang, Ce Yang, Cuiping Zhu, Qianqian Zhao, Xuehua Lu, Xiaoyu Su, Yinghao Wang.
Upper limb arthromyodynia can be treated with Notopterygium by down-regulating P2X3 to mediate PKC-induced inflammatory response
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(3): 163-175.
|
[3] |
Ling Zhang, Wei Chen, Ningning Yao, Shuzeng Hou, Zhiwei Meng, Yi Kong, Chenzhong Liao, Zhouling Xie.
Discovery of novel aspartate derivatives as highly potent and selective FXIa inhibitors
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(10): 727-737.
|
[4] |
Jingting Kang, Chao Ji.
The mechanism of galanthamine regulating IL-1β/IL-1RA ratio to ameliorate inflammatory microenvironment
[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(10): 773-781.
|
[5] |
Ling Yong, Ye Yao, Mengyi Han, Xiaoxue Yan, Qingyu Yao, Yuchen Guo, Junsheng Xue, Guoshu Chen, Tianyan Zhou.
QAP21 reduces stemness and mobility of metastatic breast cancer cells involving D1DR activation
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(4): 289-305.
|
[6] |
Shaohong Luo, Liangliang Dong, Yiyuan Li, Dan Xu, Min Chen.
Cost-effectiveness analysis of tyrosine kinase inhibitors (erlotinib, gefitinib, afatinib and osimertinib) as first-line therapy for epidermal growth factor receptor-mutated advanced non-small cell lung cancer
[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(3): 253-263.
|
[7] |
Chuhang Zhou, Xinping Hu, Qi Liu, Leqi Wang, Yuanhang Zhou, Yao Jin, Yan Liu.
Enhanced tumor-targeted delivery of anticancer drugs by folic acid-conjugated pH-sensitive polymeric micelles
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(9): 626-636.
|
[8] |
Yuqi Xie, Yushun Dou, Yue Tang.
Intranasal delivery of rapid-onset antidepressants: a new trend of treating major depressive disorder
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(8): 515-527.
|
[9] |
Xiao Cheng, Yinglin Yang, Weihan Li, Man Liu, Shanshan Zhang, Yuehua Wang, Guanhua Du.
Esculin alleviates acute kidney injury and inflammation induced by LPS in mice and its possible mechanism
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(5): 322-332.
|
[10] |
Shuxiang Song.
The research group of Pengfei Tu and Yong Jiang created the efficient discovery of a precise microfluidic assay in single-cell technique for Transient Receptor Potential Channel regulator
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(5): 372-373.
|
[11] |
Meng Lei, Xueyuan Wang, Hang Miao, Jia Wang, Sijia Sha, Jiang Zhu, Yongqiang Zhu.
Co-delivery of paclitaxel and gemcitabine via folic acid-conjugated polymeric multi-drug nanoparticles (FA-PMDNPs) for the treatment of breast cancer
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(10): 701-710.
|
[12] |
Liang Yang, Ye Yao, Yaoyao Feng, Wei Lu, Tianyan Zhou.
Pharmacodynamic model of dopamine D1 receptor agonists in the treatment of breast cancer lung metastasis
[J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(1): 45-54.
|
[13] |
Ning Li, Yingying Liang, Qi Sun, Yimin Jiang, Runtao Li, Jia Ye.
The spirocyclopiperazinium salt compound LXM-15 alleviates chronic inflammatory and neuropathic pain in mice and rats
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(6): 371-380.
|
[14] |
Beidou Zhou, Xin Wang, Zhimin Weng, Baocheng Huang, Zetong Ma, Bo Yu, Liqin Ruan, Dongbao Hu.
Synthesis and antitumor, antityrosinase, and antiplatelet aggregation activities of xanthone
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 247-256.
|
[15] |
Xiao Cheng, Huan Yang, Yinglin Yang, Weihan Li, Man Liu, Yuehua Wang, Guanhua Du.
Xiao-Xu-Ming decoction extract alleviates LPS-induced neuroinflammation associated with down-regulating TLR4/MyD88 signaling pathway in vitro and in vivo
[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(2): 88-99.
|